{"id":457349,"date":"2024-10-20T09:50:43","date_gmt":"2024-10-20T09:50:43","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/aami-11138-1-2017-r2024\/"},"modified":"2024-10-26T18:17:44","modified_gmt":"2024-10-26T18:17:44","slug":"aami-11138-1-2017-r2024","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/aami\/aami-11138-1-2017-r2024\/","title":{"rendered":"AAMI 11138 1 2017 R2024"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
1<\/td>\n | ANSI\/AAMI\/ISO 11138-1:2017\/(R)2024; Sterilization of health care products\u2014Biological indicators\u2014Part 1: General requirements <\/td>\n<\/tr>\n | ||||||
3<\/td>\n | Title page <\/td>\n<\/tr>\n | ||||||
4<\/td>\n | AAMI Standard Copyright information <\/td>\n<\/tr>\n | ||||||
5<\/td>\n | Contents <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Glossary of equivalent standards <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Committee representation <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | Background of AAMI adoption of ISO 11138-1:2017 <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 4 General manufacturing requirements 4.1 Manufacturing controls 4.1.1 Quality management systems 4.1.2 Traceability 4.1.3 Finished product requirements 4.1.4 Personnel <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 4.2 Test organism 4.2.1 Strain 4.2.2 Originating inoculum for suspension 4.2.3 Test organism count 4.3 Information to be provided by the manufacturer (labelling) <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | Table 1\u2014Information to be provided by the manufacturer 4.4 Storage and transport <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 5 Specific manufacturing requirements 5.1 Suspensions 5.2 Carrier, primary and secondary packaging 5.3 Inoculated carrier <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 5.4 Biological indicators 5.5 Self-contained biological indicators 6 Determination of population and resistance 6.1 General resistance requirements 6.2 Test organism 6.3 Population of test organisms 6.4 Resistance characteristics <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 6.5 Test conditions Table 2\u2014Minimum test samples according to method <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 7 Culture conditions 7.1 Incubator 7.2 Growth medium 7.3 Incubation 7.4 Software validation 7.5 Incubation time using detection system <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | Annex A (normative) Determination of viable count A.1 General A.2 Minimum number of test samples A.3 Sample preparation and culture methods A.4 Incubation and enumeration <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | Annex B (normative) Determination of growth inhibition by carriers and primary packaging materials exposed to sterilization processes B.1 Principle B.2 Materials B.3 Procedure <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | B.4 Interpretation of results B.5 Determination of growth inhibition by primary packaging materials <\/td>\n<\/tr>\n | ||||||
27<\/td>\n | Annex C (normative) D value determination by survivor curve method C.1 Principle C.2 Materials C.3 Procedure <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | Table C.1\u2014Examples of regression analysis <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | Table C.2\u2014Examples of calculations for slope <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | Annex D (normative) D value determination by fraction negative method D.1 Principle D.2 Materials D.3 Procedure D.3.1 Holcomb-Spearman-Karber procedure (HSKP) <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | D.3.1.1 Procedure D.3.1.2 Calculations using the HSKP <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | Table D.1\u2014Examples of data collected for HSKP <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | D.3.1.3 Example calculation of the Holcomb-Spearman-Karber procedure (HSKP) Table D.2\u2014Examples of data with non-constant time intervals and non-constant number of samples <\/td>\n<\/tr>\n | ||||||
39<\/td>\n | D.3.2 Limited Holcomb-Spearman-Karber procedure (LHSKP) D.3.2.1 Calculations using LHSKP Table D.3\u2014Examples of data collected for LHSKP with constant time intervals and constant number of samples <\/td>\n<\/tr>\n | ||||||
41<\/td>\n | D.3.2.2 Example calculations of the Limited Holcomb-Spearman-Karber procedure (LHSKP) Table D.4\u2014Examples of data with constant time intervals and constant number of samples <\/td>\n<\/tr>\n | ||||||
42<\/td>\n | D.3.3 The Stumbo-Murphy-Cochran-Procedure (SMCP) D.3.3.1 Procedure <\/td>\n<\/tr>\n | ||||||
43<\/td>\n | D.3.3.2 Calculations using the Stumbo-Murphy-Cochran-Procedure <\/td>\n<\/tr>\n | ||||||
44<\/td>\n | D.3.3.3 Example calculations of SMCP Table D.5\u2014Calculations of D value using only one data set in the fraction negative range <\/td>\n<\/tr>\n | ||||||
48<\/td>\n | Annex E (normative) Survival-kill response characteristics E.1 Principle E.2 Materials E.3 Procedure <\/td>\n<\/tr>\n | ||||||
50<\/td>\n | Annex F (informative) Relationship between components of biological indicators Table F.1\u2014Relationship between components of biological indicators <\/td>\n<\/tr>\n | ||||||
52<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" ANSI\/AAMI\/ISO 11138-1:2017\/(R)2024 – Sterilization of health care products\u2014Biological indicators\u2014Part 1: General requirements<\/b><\/p>\n |